Hard to tell from that - most of that profit could be revaluation of biological assets and inventory. No dividend - but does look hopeful for generating good cashflows in future periods. Guess we should get more prior to opening today. Meanwhile the NTA per share is a helpful guide to valuation in the absence of a dividend.
Ann: Appendix 4D, page-3
Add ATP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $54.82M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.5¢ | $25.98K | 207.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23097 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 1062028 | 6 |
View Market Depth
| Last trade - 15.46pm 17/09/2024 (20 minute delay) ? |
| ATP (ASX) Chart |